Protect Pharmaceutical Corporation
PRTT
$1.30
-$0.046-3.42%
| Weiss Ratings | PRTT - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Unrated | |||
| Risk Index | Unrated | |||
| Risk Grade | U | |||
| Reward Grade | U | |||
| Rating Factors | PRTT - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | Unrated | |||
| Growth Index | Unrated | |||
| Efficiency Index | Unrated | |||
| Solvency Index | Unrated | |||
| Total Return Index | Unrated | |||
| Volatility Index | Unrated | |||
| Beta / Standard Deviation | PRTT - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.55 | |||
| Price History | PRTT - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -22.62% | |||
| 30-Day Total Return | 26.21% | |||
| 60-Day Total Return | 128.07% | |||
| 90-Day Total Return | 48.27% | |||
| Year to Date Total Return | 125.15% | |||
| 1-Year Total Return | -50.19% | |||
| 2-Year Total Return | 52.46% | |||
| 3-Year Total Return | 161.04% | |||
| 5-Year Total Return | 550.00% | |||
| 52-Week High % Change | -56.08% | |||
| 52-Week Low % Change | 176.60% | |||
| Price | PRTT - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $2.96 | |||
| 52-Week Low Price | $0.47 | |||
| 52-Week Low Price (Date) | Dec 23, 2024 | |||
| 52-Week High Price (Date) | Apr 25, 2024 | |||
| Valuation | PRTT - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 74.69M | |||
| Enterprise Value | -- | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -- | |||
| Earnings Per Share Growth | -- | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | -- | |||
| Price/Book (Q) | -- | |||
| Enterprise Value/Revenue (TTM) | -- | |||
| Price | $1.30 | |||
| Enterprise Value/EBITDA (TTM) | -- | |||
| Enterprise Value/EBIT | -- | |||
| Market Cap Category | Micro Cap | |||
| Dividends and Shares | PRTT - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | -- | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | PRTT - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 954 292 0033 | |||
| Address | 4876 Cecile Avenue Las Vegas, NV 89115 | |||
| Website | agropharmacy.com | |||
| Country | United States | |||
| Year Founded | 1987 | |||
| Profitability | PRTT - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -- | |||
| Profit Margin | -- | |||
| Management Effectiveness | PRTT - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -- | |||
| Return on Equity | -- | |||
| Income Statement | PRTT - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | -- | |||
| Total Revenue (TTM) | -- | |||
| Revenue Per Share | -- | |||
| Gross Profit (TTM) | -- | |||
| EBITDA (TTM) | -- | |||
| EBIT (TTM) | -700.00 | |||
| Net Income (TTM) | -15.00K | |||
| Net Income Avl. to Common (TTM) | -15.00K | |||
| Total Revenue Growth (Q YOY) | -- | |||
| Earnings Growth (Q YOY) | 95.61% | |||
| EPS Diluted (TTM) | -0.01 | |||
| EPS Diluted Growth (Q YOY) | 95.57% | |||
| Balance Sheet | PRTT - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 20.10K | |||
| Cash Per Share (Q) | $0.02 | |||
| Total Current Assets (Q) | 20.10K | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | -151.60K | |||
| Current Ratio (Q) | 0.396 | |||
| Book Value Per Share (Q) | -- | |||
| Total Assets (Q) | -- | |||
| Total Current Liabilities (Q) | 50.70K | |||
| Total Debt (Q) | -- | |||
| Total Liabilities (Q) | -- | |||
| Total Common Equity (Q) | -151.60K | |||
| Cash Flow | PRTT - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -- | |||
| Cash from Financing (TTM) | 20.00K | |||
| Net Change in Cash (TTM) | 20.10K | |||
| Levered Free Cash Flow (TTM) | 1.60K | |||
| Cash from Operations (TTM) | 100.00 | |||
